Colgate-Palmolive (NYSE:CL) Stock Holdings Decreased by Hall Capital Management Co. Inc.

Hall Capital Management Co. Inc. decreased its stake in shares of Colgate-Palmolive (NYSE:CL) by 6.7% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 3,750 shares of the company’s stock after selling 269 shares during the period. Hall Capital Management Co. Inc.’s holdings in Colgate-Palmolive were worth $364,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of the company. Mitchell Sinkler & Starr PA lifted its stake in Colgate-Palmolive by 92.6% during the fourth quarter. Mitchell Sinkler & Starr PA now owns 45,899 shares of the company’s stock worth $3,659,000 after purchasing an additional 22,073 shares during the last quarter. Stonehage Fleming Financial Services Holdings Ltd grew its stake in Colgate-Palmolive by 57.1% during the 4th quarter. Stonehage Fleming Financial Services Holdings Ltd now owns 383,819 shares of the company’s stock worth $30,594,000 after buying an additional 139,429 shares during the last quarter. D L Carlson Investment Group Inc. acquired a new stake in Colgate-Palmolive in the fourth quarter worth $3,269,000. Diversify Advisory Services LLC acquired a new position in shares of Colgate-Palmolive during the first quarter valued at $911,000. Finally, Intact Investment Management Inc. boosted its holdings in shares of Colgate-Palmolive by 121.1% during the fourth quarter. Intact Investment Management Inc. now owns 32,500 shares of the company’s stock valued at $2,591,000 after acquiring an additional 17,800 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, insider Sally Massey sold 15,850 shares of the stock in a transaction on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total value of $1,636,988.00. Following the completion of the sale, the insider now owns 13,942 shares in the company, valued at $1,439,929.76. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, insider Panagiotis Tsourapas sold 14,794 shares of the business’s stock in a transaction that occurred on Thursday, August 8th. The shares were sold at an average price of $102.94, for a total transaction of $1,522,894.36. Following the transaction, the insider now directly owns 5,146 shares of the company’s stock, valued at $529,729.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Sally Massey sold 15,850 shares of the stock in a transaction that occurred on Tuesday, August 6th. The stock was sold at an average price of $103.28, for a total transaction of $1,636,988.00. Following the completion of the sale, the insider now owns 13,942 shares of the company’s stock, valued at approximately $1,439,929.76. The disclosure for this sale can be found here. Insiders have sold 43,490 shares of company stock worth $4,486,063 over the last 90 days. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Price Performance

Shares of NYSE:CL traded up $0.85 on Tuesday, reaching $105.94. 3,139,416 shares of the company traded hands, compared to its average volume of 4,342,998. The stock has a market capitalization of $86.92 billion, a PE ratio of 33.52, a P/E/G ratio of 3.54 and a beta of 0.39. The company has a debt-to-equity ratio of 16.90, a current ratio of 1.06 and a quick ratio of 0.28. The company’s 50 day moving average is $99.39 and its 200-day moving average is $93.11. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $106.04.

Colgate-Palmolive (NYSE:CL) last announced its earnings results on Friday, July 26th. The company reported $0.91 EPS for the quarter, beating the consensus estimate of $0.87 by $0.04. The business had revenue of $5.06 billion during the quarter, compared to the consensus estimate of $5 billion. Colgate-Palmolive had a return on equity of 470.19% and a net margin of 14.21%. Colgate-Palmolive’s revenue was up 4.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.77 earnings per share. As a group, analysts anticipate that Colgate-Palmolive will post 3.57 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Friday, July 19th were given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.89%. The ex-dividend date of this dividend was Friday, July 19th. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 63.29%.

Analyst Ratings Changes

A number of research analysts have issued reports on the stock. TD Cowen boosted their target price on shares of Colgate-Palmolive from $110.00 to $115.00 and gave the company a “buy” rating in a research note on Tuesday, July 30th. Barclays increased their price objective on Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a report on Monday, July 29th. Deutsche Bank Aktiengesellschaft lifted their target price on Colgate-Palmolive from $104.00 to $107.00 and gave the company a “buy” rating in a research note on Monday, July 29th. Argus increased their price target on Colgate-Palmolive from $97.00 to $107.00 and gave the stock a “buy” rating in a research note on Wednesday, May 15th. Finally, Redburn Atlantic upgraded shares of Colgate-Palmolive to a “hold” rating in a research note on Thursday, August 1st. Eight analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $101.11.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.